Concomitant Use of Antiplatelet Agents and Proton-Pump Inhibitors Increases the Risk of Adverse Cardiovascular Events: A Nationwide Population-Based Cohort Study Using Balanced Operational Definitions

Antiplatelet agents are commonly used in combination with proton-pump inhibitors (PPIs) in patients with acute coronary syndrome who are at risk of gastrointestinal hemorrhage. However, studies have reported that PPIs can alter the pharmacokinetics of antiplatelet agents and result in adverse cardio...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Hee Gyu, Kim, Dong-Kyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299643/
https://www.ncbi.nlm.nih.gov/pubmed/37367429
http://dx.doi.org/10.3390/jcdd10060264

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10299643/
https://www.ncbi.nlm.nih.gov/pubmed/37367429
http://dx.doi.org/10.3390/jcdd10060264

Ejemplares similares